Now livetag icon
Ad Intelligence Presents: Ads in ChatGPT & Google. Download the reportbanner icon
Vyleesi

April 2026

Vyleesi Market Share Analysis for April 2026

Vyleesi is an FDA Approved bremelanotide injection prescription treatment for premenopausal women with hypoactive sexual desire disorder (HSDD).
Year Founded2019
Employees51 - 200
Annual Revenue$10M - $15M
vyleesi.com
Vyleesi
Vyleesi (including company regionals)
  • vyleesi.com
    vyleesi.com
See more website traffic and engagement information

Vyleesi Revenue up to April 2026 is 10M - 15M

revenue generated by Vyleesi top domains

Vyleesi top domains revenue over 3 years

Revenue for Vyleesi top domains


Total visits to Vyleesi's top domains

Understand Vyleesi market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Vyleesi's top domains

Analyze Vyleesi engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Vyleesi's top domains

See how Vyleesi keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Vyleesi

These are the website technologies, by industry, used by Vyleesi top domains

Advertising (13)

DoubleClick

DoubleClick

Social (4)

Instagram

Instagram

Tracker (4)

Facebook Pixel

Facebook Pixel

Conversion & Analytics (3)

Google Analytics

Google Analytics

More Technologies

9

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.